Home › Trials › NCT06041698
Clinical trial No longer in our active list Interventional Ages 18 and up

Comparing text messaging and patient portal systems for reporting symptoms in multiple myeloma patients

Official title: Testing Two Implementation Strategies in Collecting ePRO Among Multiple Myeloma Patients: ePRO4MM

Run by Thomas Jefferson University · NCT06041698 · Data updated 2026-05-14

This study is no longer in our active list. It may have stopped recruiting or finished. The details below are as of 2026-05-14 and are kept for reference. Check ClinicalTrials.gov for its current status, or see similar studies below.

This study is testing whether patients with multiple myeloma prefer using text messaging or a patient portal to report their symptoms and how satisfied they are with each method.

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment200 (estimated)
SponsorThomas Jefferson University
Academic / other
Locations1 site (Philadelphia, Pennsylvania)
Trial IDNCT06041698 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates for this study are adults diagnosed with multiple myeloma who can use text messaging or have internet access.

Probably not a fit

Patients under 18 years of age or those with documented cognitive impairments may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This clinical trial evaluates patient satisfaction and engagement with two different electronic platforms for reporting symptoms among patients with multiple myeloma. Participants will be assigned to either a text messaging platform (TXT-Chatbot) or a patient portal system (MyChart) to report their health status over a period of six months. The study aims to assess patients' preferences, adherence to the chosen method, and the usability of each approach. Additionally, it will explore differences in preferences and response rates based on race and the chosen reporting method.

Why it matters

Potential benefit: If successful, this study could enhance the way patients with multiple myeloma report symptoms, potentially improving their quality of life and clinical outcomes.

How similar studies have gone: Other studies have shown success with electronic patient-reported outcomes, indicating that this approach is promising and not entirely novel.

Who can join: the full rules

Show full inclusion / exclusion criteria 
Inclusion Criteria:

* Diagnosis of MM
* Able to use TXT or have Internet access
* Can read and understand English
* If patients are undergoing an autologous stem cell transplant, they will be enrolled after their transplant

Exclusion Criteria:

* \< 18 years of age
* Cognitive impairment documented in the electronic medical record (EMR)

Where it's running

  • Sidney Kimmel Cancer Center at Thomas Jefferson University
    Philadelphia, Pennsylvania, United States     Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
View on ClinicalTrials.gov ↗ Find more trials like this →
Browse more
Multiple Myeloma 458Thomas Jefferson University 390
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.